SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
SEC Accession No. 0001193125-15-322685
Filing Date
2015-09-18
Accepted
2015-09-17 21:23:59
Documents
2

Document Format Files

Seq Description Document Type Size
1 FREE WRITING PROSPECTUS d14421dfwp.htm FWP 12882
2 GRAPHIC g14421image001.jpg GRAPHIC 36576
  Complete submission text file 0001193125-15-322685.txt   64728
Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Filed by) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: FWP
SIC: 2834 Pharmaceutical Preparations

Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Subject) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: FWP | Act: 34 | File No.: 333-205073 | Film No.: 151113872
SIC: 2834 Pharmaceutical Preparations